Risks and benefits of statins in lupus erythematosus

被引：7
作者：
Noël, B
机构：
来源：
ARCHIVES OF INTERNAL MEDICINE | 2004年 / 164卷 / 01期
关键词：
D O I：
10.1001/archinte.164.1.107-b
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：107 / 108
页数：2
相关论文
共 50 条
  • [31] Biologics in Systemic Lupus Erythematosus: Recent Evolutions and Benefits
    Kundnani, Nilima Rajpal
    Levai, Mihaela Codrina
    Popa, Mihaela-Diana
    Borza, Claudia
    Iacob, Mihai
    Mederle, Alexandra Laura
    Blidisel, Alexandru
    PHARMACEUTICS, 2024, 16 (09)
  • [32] Exercise Benefits and Considerations for Individuals With Systemic Lupus Erythematosus
    Yuen, Elizabeth P.
    Bagley, James R.
    STRENGTH AND CONDITIONING JOURNAL, 2016, 38 (06) : 69 - 75
  • [33] Should all patients with systemic lupus erythematosus receive cardioprotection with statins?
    Toloza, Sergio
    Urowitz, Murray B.
    Gladman, Dafna D.
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2007, 3 (10): : 536 - 537
  • [34] Is it Not Timely to Consider How to Balance Cardiorenometabolic Benefits and Risks of Statins? Reply
    Tawakol, Ahmed
    Emami, Hamed
    Farkouh, Michael
    Fayad, Zahi A.
    Fifer, Kenneth
    Rudd, James H. F.
    Subramanian, Sharath
    Van Dyke, Thomas
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (25) : 2881 - 2881
  • [35] ADVERSE EFFECTS OF STATINS Retraction of statins article is not in the public interest: better characterisation of benefits and risks is crucial
    Fahey, Tom
    Smith, Susan
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
  • [36] Sjogren's syndrome and systemic lupus erythematosus: links and risks
    Pasoto, Sandra Gofinet
    de Oliveira Martins, Victor Adriano
    Bonfa, Eloisa
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2019, 11 : 33 - 45
  • [37] Risks of ovulation-induction therapy in systemic lupus erythematosus
    Huong, DL
    Wechsler, B
    Piette, JC
    Arfi, S
    Gallinari, C
    Darbois, Y
    Frances, C
    Godeau, P
    BRITISH JOURNAL OF RHEUMATOLOGY, 1996, 35 (11): : 1184 - 1186
  • [38] Inflammation, dyslipidemia and risks of ischemic strokes in systemic lupus erythematosus
    Mikdashi, Jamal
    FUTURE LIPIDOLOGY, 2007, 2 (05): : 489 - 493
  • [39] Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets
    Crow, Mary K.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (08) : 999 - 1014
  • [40] ATHEROSCLEROSIS AND CARDIOVASCULAR DISEASE IN SYSTEMIC LUPUS ERYTHEMATOSUS. EFFECTS OF STATINS TREATMENT
    Barbarroja, N.
    Ruiz-Limon, P.
    Perez-Sanchez, C.
    Aguirre, M. A.
    Khamastha, M. A.
    Rodriguez-Ariza, A.
    Gonzalez-Reyes, J. A.
    Kraiwesh, H.
    Villalba-Montoro, J. M.
    Collantes-Estevez, E.
    Cuadrado, M. J.
    Lopez-Pedrera, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 865 - 865
12345